2026-06-28T09:58:56Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/gjct.000014 2017-03-07 PTZ.GJCT:VOL3

Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language Daniela Russo# Francesco Merolla# Gennaro Ilardi Silvia Varricchio Danila Caroppo Virginia Napolitano Massimo MascoloStefania Staibano<p>Oral cavity squamous cell cancer (OSCC) and Oropharynx squamous cell carcinoma (OPSCC) are the most frequent forms of Head and Neck Cancers (HNCs) [1]. About 300,000 new cases of oral cancers are being counted yearly worldwide, having registered an increase of incidence of 225% in U.S.A. in the last 20 years, with about 50% of related deaths [2,3]. The relevant advances in treatments of OSCC during the last decades, allowed updated surgery techniques, robotic surgery, intensive induction chemotherapy and hyperfractionated radiotherapy to be currently applied to the advanced cases. Unfortunately, most of these therapies often carry severe acute and chronic side effects, heavily impacting on patients’ quality of life.</p> Global Journal of Cancer Therapy - Peertechz Publications 2017-03-07 Short Communication https://doi.org/10.17352/gjct.000014 en Copyright © Daniela Russo# et al.